Tongji Hospital
Clinical trials sponsored by Tongji Hospital, explained in plain language.
-
New approach aims to fight cancer and ease pain at the same time
Disease control Recruiting nowThis study is for people with advanced bile duct or pancreatic cancer who are experiencing significant pain. It aims to see if starting standard cancer drugs at the same time as a specialized pain-blocking injection (Celiac Plexus Block) works better than usual care. Researchers …
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
New drug combo tested in fight against tough liver cancer
Disease control Recruiting nowThis study is testing a combination of an immunotherapy drug (tislelizumab) and a traditional Chinese herbal granule (Huaier) as the first treatment for advanced liver cancer that cannot be removed by surgery. It will involve 94 patients to see if this combo can shrink tumors, co…
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Four-Drug attack on rare brain cancer shows promise in clinical trial
Disease control Recruiting nowThis study is testing whether adding two newer drugs (sintilimab and pirtobrutinib) to standard chemotherapy (methotrexate and rituximab) works better for people with newly diagnosed primary central nervous system lymphoma (PCNSL), a rare brain cancer. Researchers will compare th…
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New surgical technique aims to tame stubborn sinus inflammation
Disease control Recruiting nowThis study is testing whether adding a procedure to remove lymphoid tissue in the back of the nose during standard sinus surgery provides better long-term control of inflammation and reduces polyp recurrence. Thirty-two adults with chronic sinusitis and nasal polyps will be rando…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New brain surgery technique aims to save lives and reduce disability from severe strokes
Disease control Recruiting nowThis large study is testing a new, less invasive procedure for treating a severe type of stroke caused by bleeding in the brain. It compares a precise surgery to drain the blood clot using a special drug against standard medical care. The main goal is to see if this approach help…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
5-Year hope for kids battling rare metabolic disorder
Disease control Recruiting nowThis study is testing how well glycerol phenylbutyrate controls ammonia levels in Chinese children with rare urea cycle disorders over five years. It will enroll 40 children aged 0-18 who haven't used this medication recently. Researchers will track blood ammonia, growth, brain d…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
AI vs. liver cancer: computer model aims to stop recurrence before it starts
Disease control Recruiting nowThis study is testing a new approach to prevent early-stage liver cancer from coming back after surgery. An artificial intelligence (AI) model will analyze patient scans and data to predict who is at high risk for recurrence. Those high-risk patients will then receive a personali…
Phase: PHASE1, PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
One-Shot treatment tested to reset immune system in severe autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new one-time treatment called V001-BCMA for people with severe autoimmune diseases that have not responded to standard therapies. The treatment uses a patient's own modified immune cells (CAR-T cells) to target and remove harmful B cells that d…
Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists test virus that hunts and kills bladder cancer cells
Disease control Recruiting nowThis early-stage study is testing a new treatment called KD01, which is a modified virus designed to infect and destroy bladder cancer cells. It is given directly into the bladder of patients with high-risk non-muscle-invasive or muscle-invasive bladder cancer. The main goals are…
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Tracking new treatments for rare nerve disease
Disease control Recruiting nowThis study is a registry that will track 200 adults in China who have a specific type of neuromyelitis optica spectrum disorder (NMOSD) and are already receiving a monoclonal antibody treatment. The goal is to see how well these treatments work and how safe they are in real-world…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Special baby formula tested to help infants through liver surgery
Disease control Recruiting nowThis study is testing whether a special nutritional formula given to infants around the time of their biliary atresia surgery can help them grow better and improve their recovery. It will compare this special formula to standard feeding in 120 infants under 3 months old at multip…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Doctors test Cancer-Killing virus in Women's health battle
Disease control Recruiting nowThis early-stage study is testing a new treatment called KD01, which is a specially engineered virus designed to infect and kill cancer cells. It is being given as a direct injection to women with cervical or endometrial cancer who have not responded to other treatments. The main…
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug aims to prevent heart damage after surgery
Disease control Recruiting nowThis study is testing if a new anesthetic drug called Ciprofol is better than the standard drug, propofol, at preventing heart injury in patients having lung surgery. It will involve over 1,000 adults aged 45-80 undergoing common lung procedures. The main goal is to see if Ciprof…
Phase: PHASE4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Ancient remedy put to modern test in stroke recovery race
Disease control Recruiting nowThis study is testing whether two different versions of a traditional Chinese medicine pill work equally well for people who have just had a stroke. Researchers will follow 100 stroke patients for about three months to see which pill helps them recover better in terms of movement…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Spinal fluid injection trial offers hope for rare nerve disease
Disease control Recruiting nowThis early-stage trial is testing whether tiny particles derived from human neural stem cells, called NouvSoma001, can help control neuromyelitis optica spectrum disorders (NMOSD). The study will first find a safe dose by giving the treatment via spinal tap to small groups, then …
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Four-Drug attack on tough bile duct cancer
Disease control Recruiting nowThis study is testing a new four-drug combination for people with advanced bile duct cancer that cannot be removed by surgery. All participants will receive the same treatment, which adds two new drugs (adebrelimab and simvastatin) to standard chemotherapy. The main goal is to se…
Phase: PHASE1, PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug trial offers hope for stiff, painful back condition
Disease control Recruiting nowThis study is testing the safety and effectiveness of the drug secukinumab in 100 Chinese adults with active ankylosing spondylitis, a painful inflammatory spine disease. Participants have not gotten enough relief from standard anti-inflammatory drugs and have not tried advanced …
Phase: PHASE4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for lupus patients with lung damage
Disease control Recruiting nowThis study is testing if a newer drug called Telitacicept is better and safer than the standard treatment, Cyclophosphamide, for controlling lung scarring in people with early lupus. It will involve 100 adults who have both lupus and signs of lung disease. The main goal is to see…
Phase: PHASE4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New immune cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis is an early-stage study testing a new type of CAR-T cell therapy called CT1190B. It aims to see if this treatment is safe and effective for adults with B-cell non-Hodgkin lymphoma that has come back or hasn't responded to standard treatments. The study will also look at how …
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Feb 19, 2026 14:38 UTC
-
Breakthrough blood test could spot breast cancer earlier
Diagnosis Recruiting nowThis study is testing a new method to detect breast cancer using a simple blood test. Researchers want to see if this new test is accurate and reliable for finding cancer signals. The trial is recruiting 100 healthy volunteers to help validate the test's performance.
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
New scan could replace risky biopsies for kidney transplant patients
Diagnosis Recruiting nowThis study is testing a new type of MRI scan to check the health of transplanted kidneys without needles, contrast dye, or invasive biopsies. It aims to create a personalized 'baseline' for each kidney by scanning donors before donation, allowing for more sensitive, early detecti…
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Mar 31, 2026 12:10 UTC
-
AI steps in: can a computer Out-Diagnose doctors on brain scans?
Diagnosis Recruiting nowThis study is developing and testing an artificial intelligence (AI) tool designed to help doctors diagnose brain diseases from MRI scans. It will use brain scan data from 1,000 patients with conditions like tumors, stroke, or Alzheimer's to see if the AI can match or improve dia…
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC
-
New scan aims to replace liver biopsies for fatty liver disease
Diagnosis Recruiting nowThis study is testing whether a new type of MRI scan can accurately assess fatty liver disease without needing a painful liver biopsy. Researchers will enroll 500 patients to see if the scan's measurements match the results from biopsies, which is the current best test. The goal …
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Mar 20, 2026 14:48 UTC
-
AI predicts Cancer's next move
Diagnosis Recruiting nowThis study is testing a new artificial intelligence (AI) tool designed to predict which patients are at high risk of their colorectal cancer spreading to the liver after curative surgery. The tool analyzes patients' routine CT scans, pathology images, and clinical data. The goal …
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Mar 10, 2026 12:53 UTC
-
Flu shot could be a lifesaver for recent heart attack patients
Prevention Recruiting nowThis study is testing if getting a flu shot can help prevent serious heart problems in people who recently had a heart attack or similar event. Researchers will give about 6,600 participants either a real flu shot or a placebo (dummy shot) and then track their health for a year. …
Phase: NA • Sponsor: Tongji Hospital • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC
-
Numbing shot during surgery could prevent dangerous lung complications
Symptom relief Recruiting nowThis study is looking at whether a numbing injection near the spine, given during chest surgery, helps reduce serious problems afterward like lung infections and breathing failure. Researchers will observe 500 patients having minimally invasive chest surgery, checking their pain,…
Phase: NA • Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Safer sleep for Kids' surgery? study tests anesthesia to prevent breathing scares
Symptom relief Recruiting nowThis study aims to find out which of two common anesthesia drugs causes fewer breathing problems during and after tonsil surgery in children. Researchers will compare remimazolam and ciprofol in 114 children aged 2-12. The goal is to improve safety and recovery for kids undergoin…
Phase: PHASE4 • Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Mar 20, 2026 14:47 UTC
-
Doctors review past treatments for rare fever disorder
Knowledge-focused Recruiting nowThis study looks back at the medical records of 12 people with Familial Mediterranean Fever (FMF) to see how well different medications worked for them in real life. Researchers are not testing new treatments but are observing what happened when patients took existing drugs. The …
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
AI steps in to forecast liver Cancer's return
Knowledge-focused Recruiting nowThis study is testing a new artificial intelligence (AI) tool designed to predict if and how a patient's early-stage liver cancer might return after surgery. Researchers will follow 353 patients for two years after their operation to see if the AI's predictions about high-risk re…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists hunt blood clues to predict deadly strokes
Knowledge-focused Recruiting nowThis study aims to discover biological markers in blood and other samples that could help identify people at high risk for stroke before it happens. Researchers will follow 7,000 participants—both stroke patients and healthy individuals—for up to four years, tracking their health…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Study seeks safer anesthesia for elderly hip surgery patients
Knowledge-focused Recruiting nowThis study aims to find out if spinal anesthesia or general anesthesia leads to fewer lung problems after hip fracture surgery in older adults. It will enroll 40 patients aged 65+ whose surgery is delayed more than 48 hours. Researchers will compare oxygen levels, lung function, …
Phase: NA • Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
AI scans your past to predict your cancer future
Knowledge-focused Recruiting nowThis study aims to create an artificial intelligence (AI) tool that can predict which colorectal cancer patients are at high risk of the cancer spreading to their liver after curative surgery. Researchers will develop the tool by analyzing existing medical records, CT scans, and …
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC
-
Scientists probe hidden gut impact of common medical procedure
Knowledge-focused Recruiting nowThis study aims to understand how the laxative used to clean the bowel before a colonoscopy affects the community of bacteria living in the gut, especially in people who have had their gallbladder removed. Researchers will compare 10 people who have had gallbladder surgery with 1…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC
-
Massive 50,000-Person study launches to unlock headache mysteries
Knowledge-focused Recruiting nowThis is a large, long-term observational study that aims to collect detailed information from 50,000 people with headaches over 10 years. The goal is to better understand the different causes and patterns of headaches by tracking patients' symptoms, treatments, and health data. R…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC
-
Can your mood change your cancer treatment outcome?
Knowledge-focused Recruiting nowThis study aims to understand if anxiety or depression (emotional distress) affects how well immunotherapy works for people with liver cancer. It will follow 651 patients receiving standard immunotherapy to see if their mental health influences how long the treatment keeps the ca…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:52 UTC